Effect of NEUROAID on Stroke
- Conditions
- Cerebral ischemic stroke.Cerebral infarction due to thrombosis of cerebral arteries
- Registration Number
- IRCT138905103663N2
- Lead Sponsor
- Shafa Yaab Drug company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 72
Having ischemic cerebral infarction confirmed by imaging (CT scan or MRI) in the territory of middle cerebral artery, Admission on hospital during 24 hours after the event, Age older than 60 years old, Subjects or legally acceptable representative (first degree relatives) is willing and able to provide written informed consent, Having the ability to swallow normally and to comply the study schedule of treatment.
Exclusion criteria: Having the evidence of intra-cerebral hemorrhage or hemorrhagic conversion on brain imaging, Any other brain pathology other than current ischemic infarction, Previous history of stroke, Signing old stroke in brain imaging, Existence of systemic disease: COPD, severe asthma, CO2 narcosis, renal failure, severe congestive heart failure, uncontrolled hypertension, uremia, cirrhosis, psychosis, dementia
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient's function. Timepoint: Before intervention and one week and 3 months after intervention. Method of measurement: By means of Barthele-MRS index.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: Every month for three months. Method of measurement: By checklist and assessment by researcher and patient, and monthly visit.